NEW YORK (GenomeWeb) – Ohio State University's cancer institute and the Moffitt Cancer Center have launched a collaboration that will use data and samples from more than 100,000 patients to create a new resource to connect patients and physicians with precision medicine researchers.

Moffitt will team with The OSU Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) to form the Oncology Research Information Exchange Network (ORIEN), the partners said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.